Clinical Trials
Showing 1167 Clinical Trials-
Start Date: June 2022 Updated: January 2019
Buenos Aires, ArgentinaKetamine
Phase 4
Completed
-
Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use
Start Date: June 2022 Updated: June 2022
Psilocybin
Phase 2
Not yet recruiting
-
Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans
Start Date: June 2022 Updated: December 2021
MDMA
Phase 2
Not yet recruiting
-
Psilocybin Therapy for Chronic Low Back Pain
Start Date: June 2022 Updated: May 2022
Psilocybin
Phase 1|Phase 2
Not yet recruiting
-
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD
Start Date: June 2022 Updated: May 2022
Psilocybin
Phase 2
Not yet recruiting
-
The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
Start Date: June 2022 Updated: May 2022
Psilocybin
Phase 2
Recruiting
-
Comparing the Effects of Psilocin and Psilocybin in Healthy Adults
Start Date: May 2022 Updated: June 2022
San Francisco, California, USAPsilocybin
Phase 1
Recruiting
-
Ketamine and Refractory Painful Care in a Palliative Unit
Start Date: May 2022 Updated: March 2020
Lomme, Hauts-de-France, FranceKetamine
Phase 4
Terminated
-
Start Date: May 2022 Updated: September 2018
Ketamine
Phase 2
Completed
-
Ketamine Infusions for PTSD and Treatment-Resistant Depression
Start Date: May 2022 Updated: May 2019
Minneapolis, Minnesota, USAKetamine
Phase 1
Completed